pre-seed
Stage
1
Investors
About
Enjamb Labs offers an AI-driven platform that orchestrates and automates the drug development process by integrating clinical evidence synthesis, trial design, statistical programming, and regulatory document generation in a single auditable workspace connected to existing pharmaceutical systems.
Explore Enjamb Labs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.